Patent Assignment
Reel/Frame 056441/0365
Assignment of Assignor's Interest
Recorded: 2021-06-04
Pages: 7
Assignors
WILSON, NICHOLAS STUART
Executed: 2016-06-15
SAVITSKY, DAVID ADAM
Executed: 2016-06-09
FINDEIS, MARK ARTHUR
Executed: 2016-06-09
Assignee
AGENUS INC.
3 FORBES ROAD, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Anti-Ctla-4 Antibodies and Methods of Use Thereof
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 4, 2021
From: VAN DIJK, MARC; MUNDT, CORNELIA ANNE
To: 4-ANTIBODY AG
Reel/Frame 056441/0389 →
Assignment of Assignor's Interest
Jun 4, 2021
From: 4-ANTIBODY AG
To: AGENUS INC.
Reel/Frame 056441/0400 →
Assignment of Assignor's Interest
Jun 4, 2021
From: RITTER, GERD
To: LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
Reel/Frame 056441/0428 →
Assignment of Assignor's Interest
Jun 4, 2021
From: WOLCHOK, JEDD DAVID; MERGHOUB, TAHA; SCHAER, DAVID
To: MERMORIAL SLOAN KETTERING CANCER CENTER
Reel/Frame 056441/0498 →
Security Interest
Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Patent Security Agreement
Aug 18, 2023
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064641/0263 →
Amended and Restated Patent Security Agreement
Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →
Security Interest
Mar 31, 2025
From: AGENUS, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 070680/0634 →